Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Antimicrobial Agents and Chemotherapy
|
August 1, 1993
WIN 54954 treatment of mice infected with a diabetogenic strain of group B coxsackievirus
D M See, J G Tilles
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
October 8, 1997
Occurrence of coxsackievirus hepatitis in baby rabbits and protection by a formalin-inactivated polyvalent vaccine
D M See, J G Tilles
Clinical and Diagnostic Virology
|
July 1, 1998
The pathogenesis of viral-induced diabetes
D M See, J G Tilles
Scandinavian Journal of Infectious Diseases
|
January 1, 1994
Efficacy of a polyvalent inactivated-virus vaccine in protecting mice from infection with clinical strains of group B coxsackieviruses
D M See, J G Tilles
The Journal of Infectious Diseases
|
May 1, 1995
Pathogenesis of virus-induced diabetes in mice
D M See, J G Tilles
Antimicrobial Agents and Chemotherapy
|
February 1, 1992
Treatment of Coxsackievirus A9 myocarditis in mice with WIN 54954
D M See, J G Tilles
Reviews of Infectious Diseases
|
September 1, 1991
Viral myocarditis
D M See, J G Tilles
Immunological Investigations
|
January 1, 1996
alpha-Interferon treatment of patients with chronic fatigue syndrome
D M See, J G Tilles
Clinical and Diagnostic Virology
|
July 1, 1998
Demonstration of persistent enterovirus in the pancreas of diabetic mice by in situ polymerase chain reaction
M M Berger, D M See, M Aymard, et al.
Immunopharmacology
|
January 1, 1997
In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients
D M See, N Broumand, L Sahl, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Antimicrobial Agents and Chemotherapy
|
August 1, 1993
WIN 54954 treatment of mice infected with a diabetogenic strain of group B coxsackievirus
D M See, J G Tilles
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
October 8, 1997
Occurrence of coxsackievirus hepatitis in baby rabbits and protection by a formalin-inactivated polyvalent vaccine
D M See, J G Tilles
Clinical and Diagnostic Virology
|
July 1, 1998
The pathogenesis of viral-induced diabetes
D M See, J G Tilles
Scandinavian Journal of Infectious Diseases
|
January 1, 1994
Efficacy of a polyvalent inactivated-virus vaccine in protecting mice from infection with clinical strains of group B coxsackieviruses
D M See, J G Tilles
The Journal of Infectious Diseases
|
May 1, 1995
Pathogenesis of virus-induced diabetes in mice
D M See, J G Tilles
Antimicrobial Agents and Chemotherapy
|
February 1, 1992
Treatment of Coxsackievirus A9 myocarditis in mice with WIN 54954
D M See, J G Tilles
Reviews of Infectious Diseases
|
September 1, 1991
Viral myocarditis
D M See, J G Tilles
Immunological Investigations
|
January 1, 1996
alpha-Interferon treatment of patients with chronic fatigue syndrome
D M See, J G Tilles
Clinical and Diagnostic Virology
|
July 1, 1998
Demonstration of persistent enterovirus in the pancreas of diabetic mice by in situ polymerase chain reaction
M M Berger, D M See, M Aymard, et al.
Immunopharmacology
|
January 1, 1997
In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients
D M See, N Broumand, L Sahl, et al.
Page
of 2